Semin Neurol 2014; 34(05): 534-541
DOI: 10.1055/s-0034-1396007
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Amyotrophic Lateral Sclerosis

Rabia Malik
1   Department of Neurology, UCSF Medical Center, San Francisco, California
,
Andrew Lui
2   Department of Physical Therapy and Rehabilitation Science, UCSF Medical Center, San Francisco, California
,
Catherine Lomen-Hoerth
1   Department of Neurology, UCSF Medical Center, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
17 December 2014 (online)

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting 20,000 to 30,000 people in the United States. The mainstay of care of patients affected by this disease is supportive and given the multifaceted nature of their needs is provided most efficiently through multidisciplinary clinics that have shown to prolong survival and improve quality of life. The authors discuss in detail evidence-based management of individuals affected by this condition.

 
  • References

  • 1 Geser F, Brandmeir NJ, Kwong LK , et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008; 65 (5) 636-641
  • 2 Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 1989; 80 (2) 114-117
  • 3 Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012; 69 (11) 1410-1416
  • 4 Shook SJ, Pioro EP. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Ann Neurol 2009; 65 (Suppl. 01) S10-S16
  • 5 Miller RG, Jackson CE, Kasarskis EJ , et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73 (15) 1227-1233
  • 6 Lewis M, Rushanan S. The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis. NeuroRehabilitation 2007; 22 (6) 451-461
  • 7 Gruis KL, Wren PA, Huggins JE. Amyotrophic lateral sclerosis patients' self-reported satisfaction with assistive technology. Muscle Nerve 2011; 43 (5) 643-647
  • 8 Pizzi A, Carlucci G, Falsini C, Verdesca S, Grippo A. Application of a volar static splint in poststroke spasticity of the upper limb. Arch Phys Med Rehabil 2005; 86 (9) 1855-1859
  • 9 Dieruf K, Poole JL, Gregory C, Rodriguez EJ, Spizman C. Comparative effectiveness of the GivMohr sling in subjects with flaccid upper limbs on subluxation through radiologic analysis. Arch Phys Med Rehabil 2005; 86 (12) 2324-2329
  • 10 Brooke MM, de Lateur BJ, Diana-Rigby GC, Questad KA. Shoulder subluxation in hemiplegia: effects of three different supports. Arch Phys Med Rehabil 1991; 72 (8) 582-586
  • 11 Jackson CE, Bryan WW. Amyotrophic lateral sclerosis. Semin Neurol 1998; 18 (1) 27-39
  • 12 Foley MP, Prax B, Crowell R, Boone T. Effects of assistive devices on cardiorespiratory demands in older adults. Phys Ther 1996; 76 (12) 1313-1319
  • 13 Trail M, Nelson N, Van JN, Appel SH, Lai EC. Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. Arch Phys Med Rehabil 2001; 82 (1) 98-102
  • 14 Ward AL, Sanjak M, Duffy K , et al. Power wheelchair prescription, utilization, satisfaction, and cost for patients with ALS: preliminary data for evidence based guidelines. Arch Phys Med Rehabil 2010; 91 (2) 268-272
  • 15 Zhuang Z, Stobbe TJ, Collins JW, Hsiao H, Hobbs GR. Psychophysical assessment of assistive devices for transferring patients/residents. Appl Ergon 2000; 31 (1) 35-44
  • 16 Chen LK, Mann WC, Tomita MR, Burford TE. An evaluation of reachers for use by older persons with disabilities. Assist Technol 1998; 10 (2) 113-125
  • 17 Kling C, Persson A, Gardulf A. The ADL ability and use of technical aids in persons with late effects of polio. Am J Occup Ther 2002; 56 (4) 457-461
  • 18 Mitchell SC. Dressing aids. BMJ 1991; 302 (6769) 167-169
  • 19 Roth GM. The sock donner. Am J Occup Ther 1969; 23 (1) 75-76
  • 20 Dallas MJ, White LW. Clothing fasteners for women with arthritis. Am J Occup Ther 1982; 36 (8) 515-518
  • 21 Fuller Y, Trombly CA. Effects of object characteristics on female grasp patterns. Am J Occup Ther 1997; 51 (7) 481-487 , discussion 489
  • 22 Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2004; 29 (5) 656-662
  • 23 Liebetanz D, Hagemann K, von Lewinski F, Kahler E, Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 2004; 20 (11) 3115-3120
  • 24 Veldink JH, Bär PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 2003; 13 (9) 737-743
  • 25 Kaspar BK, Frost LM, Christian L, Umapathi P, Gage FH. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 2005; 57 (5) 649-655
  • 26 Carreras I, Yuruker S, Aytan N , et al. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res 2010; 1313: 192-201
  • 27 Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003; 53 (6) 804-807
  • 28 Deforges S, Branchu J, Biondi O , et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol 2009; 587 (Pt 14) 3561-3572
  • 29 Lui AJ, Byl NN. A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis. J Neurol Phys Ther 2009; 33 (2) 68-87
  • 30 Dal Bello-Haas V, Florence JM. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2013; 5: CD005229
  • 31 Chen A, Montes J, Mitsumoto H. The role of exercise in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 2008; 19 (3) 545-557, ix–x ix–x.
  • 32 Sanjak M, Paulson D, Sufit R , et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 1987; 37 (7) 1217-1220
  • 33 Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis. A case report. Phys Ther 1983; 63 (6) 965-968
  • 34 Sanjak M, Reddan W, Brooks BR. Role of muscular exercise in amyotrophic lateral sclerosis. Neurol Clin 1987; 5 (2) 251-268 , vi
  • 35 Bello-Haas VD, Florence JM, Kloos AD , et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007; 68 (23) 2003-2007
  • 36 Dal Bello-Haas V, Kloos AD, Mitsumoto H. Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther 1998; 78 (12) 1312-1324
  • 37 Hardiman O. Management of respiratory symptoms in ALS. J Neurol 2011; 258 (3) 359-365
  • 38 Atalaia A, De Carvalho M, Evangelista T, Pinto A. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler 2007; 8 (2) 101-105
  • 39 Shimizu T, Komori T, Kugio Y, Fujimaki Y, Oyanagi K, Hayashi H. Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010; 11 (1-2) 57-62
  • 40 Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005; 171 (3) 269-274
  • 41 Miller RG, Jackson CE, Kasarskis EJ , et al; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73 (15) 1218-1226
  • 42 Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999; 164 (1) 82-88
  • 43 Mahajan KR, Bach JR, Saporito L, Perez N. Diaphragm pacing and noninvasive respiratory management of amyotrophic lateral sclerosis/motor neuron disease. Muscle Nerve 2012; 46 (6) 851-855
  • 44 Francis K, Bach JR, DeLisa JA. Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 1999; 80 (8) 951-963
  • 45 Tomik B, Guiloff RJ. Dysarthria in amyotrophic lateral sclerosis: a review. Amyotroph Lateral Scler 2010; 11 (1-2) 4-15
  • 46 Spataro R, Ciriacono M, Manno C, La Bella V. The eye-tracking computer device for communication in amyotrophic lateral sclerosis. Acta Neurol Scand 2014; 130 (1) 40-45
  • 47 Ngo ST, Steyn FJ, McCombe PA. Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis. J Neurol Sci 2014; 340 (1-2) 5-12
  • 48 Goyal NA, Mozaffar T. Respiratory and nutritional support in amyotrophic lateral sclerosis. Curr Treat Options Neurol 2014; 16 (2) 270
  • 49 Baldinger R, Katzberg HD, Weber M. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2012; 4: CD004157
  • 50 McClelland III S, Bethoux FA, Boulis NM , et al. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. Muscle Nerve 2008; 37 (3) 396-398
  • 51 Sanjak M, Bravver E, Bockenek WL, Norton HJ, Brooks BR. Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study. Arch Phys Med Rehabil 2010; 91 (12) 1920-1929
  • 52 Johns Hopkins University. Trial of resistance and endurance exercise in amyotrophic lateral sclerosis (ALS). NLM Identifier: NCT01521728. Bethesda, MD: National Library of Medicine. 2000. Available at: http://clinicaltrials.gov/show/NCT01521728 . Accessed May 5, 2014
  • 53 State University of New York – Upstate Medical University. Diaphragm pacing system (DPS) in participants with amyotrophic lateral sclerosis (ALS) (DPS in ALS). NLM Identifier: NCT01938495. Bethesda, MD: National Library of Medicine. 2000. Available at: http://clinicaltrials.gov/show/NCT01938495 . Accessed May 5, 2014
  • 54 Lee B, Liu CY, Apuzzo ML. A primer on brain–machine interfaces, concepts, and technology: a key element in the future of functional neurorestoration. World Neurosurg 2013; 79 (3-4) 457-471
  • 55 McCane LM, Sellers EW, McFarland DJ , et al. Brain-computer interface (BCI) evaluation in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (3-4) 207-215